KMD Bioscience

KMD Bioscience Co., Ltd. was established in Tianjin, China in 2014. The founder team has many years of experiences in human drug research and development. KMD Bioscience takes research & development as the foundation of its value and focuses on providing high-quality products and drug-antibody discovery services for global scientists, research institutes and pharmaceutical companies. As a high-tech enterprise in China, KMD Bioscience has successfully obtained the ISO9001:2015 quality management system certification and national patent pilot laboratory honor. At present, the company has more than 30 patents and 2 registered trademarks. KMD Bioscience provides more than 800+ technical service consulting, custom service design and project delivery for research institutes, hospitals, pharmaceutical companies and biological companies worldwide every year.At the beginning of its establishment, KMD Bioscience started from the phage display technology platform to provide high-quality antibody discovery services, and gradually established stable cell line construction and screening, natural protein extraction and fermentation, and recombinant protein custom expression services, a multi-species antibody discovery platform. Based on the above-mentioned major R&D platforms, KMD Bioscience has successfully developed many related reagents such as recombinant proteins, antibodies, antibody-drug similars, industrial enzymes, and diagnostic raw materials for scientific research and new drug discovery.

Research Area and Skills

Recognize this scientist’s Expertise for their contribution in your research

Biochemistry 0 Biological Engineering 0 Biomedical Science 0 Cell Biology 0 Drug Screening 0 Drug Discovery 0 Protein Engineering 0


  • Post
  • Publication
  • Plasmid
  • Following (0)
  • Follower (0)

1. Production method of nano antibodyThe development of nano antibodies is different from the traditional monoclonal antibody Production method by hybridoma, which generally selects candidate nano antibodies by immunizing alpaca, constructing phage library and displaying phage, ...Learn More

Nanobodies (Nbs), a new type of antibody, first discovered in camel blood by Belgian scientist Hamers et al. Compared with traditional antibodies, Nanobody, whose molecular weight is only about 15 KDa, does not have a light chain, only a heavy chain antibody (HcAb) and two ...Learn More

1. Basic principle[1]Monoclonal antibodies are highly homogeneous antibodies produced from a single B cell clone that target only a specific epitope. Hybridoma antibody technology is based on cell fusion technology, which fuses sensitized B cells with the ability to secrete ...Learn More

Fluorescence In Situ Hybridization1.Principle of Fluorescence In Situ HybridizationFluorescent molecules can be deposited in chromatin at the sites of specific DNA sequences by use of fluorescence in situ hybridization (FISH). The technique is a simple one. DNA or RNA sequences ...Learn More

Peptide synthesis and antigen preparation Hapten is a substance that is only immune reactive, but not immunogenic, so it is also called incomplete antigen. Small molecules belong to haptens, which need to be connected with large molecular substances (carriers) to form ...Learn More

This guy hasn’t publications anything yet.

This guy hasn’t plasmids anything yet.

Hot plasmids

This guy has no following anyone.

Popular Cloud Scientists

This guy has no follower now.

Cloud Scientists

About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2023 MolecularCloud